Send us a text

I’m honored to welcome Randall Feingold, a renowned plastic surgeon and respected member of the American Society of Plastic Surgeons (ASPS), where he also serves on the committee for Breast Implant Illness. Dr. Feingold has been a steadfast voice advocating for women’s health, raising international awareness about the risks of breast implants, the importance of safe and supportive explant recovery, and the urgent need for stronger safety measures and regulations around breast implants. His dedication and expertise continue to inspire and empower women on their healing journeys.

FDA Black-Box Warning for Breast Implants (Example Text Per FDA Guidance)

According to the FDA’s labeling guidance (October 2021) and example from Appendix A, the boxed warning should state:

• Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.
• Breast implants have been associated with the development of a cancer of the immune system called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.
• Patients receiving breast implants have reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.
  U.S. Food and Drug Administration
  facingourrisk.org
  PMC

Why This Matters

1. "Not lifetime devices" underscores that implants often require monitoring, maintenance, or replacement over time—especially relevant for women navigating healing post-explant, where long-term awareness is key.
2. Risk of BIA-ALCL, particularly with textured implants, highlights a serious health concern—knowing this can inform safer decision-making.
3. Systemic symptoms (Breast Implant Illness – BII) such as fatigue, brain fog, autoimmune issues—emphasize that some experiences are physiological and may improve post-explant, aligning closely with your holistic healing approach.

Additional Context and Support for Your Work

• The FDA also requires a Patient Decision Checklist detailing when implants shouldn't be used, risks of surgery, BIA-ALCL, systemic symptoms, and alternatives—reinforced with signatures from both patient and physician
  U.S. Food and Drug Administration+1
  facingourrisk.org.
• Updated guidance includes rupture screening intervals, device material transparency, and patient device cards to improve patient empowerment and tracking
  U.S. Food and Drug Administration
  

Leoracoca@gmail.com

Send us a text

1 source

A conversation explores the use of autologous fat transfers in various cosmetic and reconstructive procedures. The primary focus is on breast augmentation and reconstruction following mastectomies or explant surgery, offering a natural alternative to implants. The doctors discuss techniques for harvesting and transferring fat, highlighting its regenerative capabilities, particularly in reversing radiation damage. Furthermore, they touch on the application of fat transfers for aesthetic purposes, including addressing wrinkles and improving skin texture using derivatives from the patient's blood. This innovative approach utilizes the body's own resources to restore tissue health and volume.

Email: rfeingold@nybra.com

Leoracoca@gmail.com

Leoracoca@gmail.com

Send us a text

Dr. Randall Feingold, a plastic surgeon, and Dr. Brian Clement, founder of the Hippocrates Health Institute, discuss the impact of breast implants on women's health. The conversation explores the potential role of the implant's plastic shell in causing systemic symptoms, even with saline implants, and the importance of lymphatic system health. Dr. Clement emphasizes the Hippocrates Institute's approach to detoxification, raw food diets, and energy medicine to combat inflammation and support overall well-being. They discuss the use of exosomes and autologous fat transfers as regenerative medicine techniques. Dr. Feingold highlights the importance of proper explantation techniques and breast restoration, while Dr. Clement advocates for a shift towards respecting biology and nature in healthcare. Both doctors express concerns about the current medical system's focus on profit over patient well-being and promote a more holistic, nature-based approach to health.

Leoracoca@gmail.com